{
    "id": "correct_subsidiary_00034_0",
    "rank": 21,
    "data": {
        "url": "http://www.talloakscapital.com/page137.html",
        "read_more_link": "",
        "language": "en",
        "title": "Current News",
        "top_image": "",
        "meta_img": "",
        "images": [
            "http://www.talloakscapital.com/images/logo.gif",
            "http://www.talloakscapital.com/stuff/contentmgr/files/6c935d877c79468dc0a79d74c927f40f/mouseoutgraphic/home0.gif",
            "http://www.talloakscapital.com/stuff/contentmgr/files/fb425dc0c5ac02c3a8f2e251cf493851/mouseoutgraphic/directions0.gif",
            "http://www.talloakscapital.com/stuff/contentmgr/files/6b69cd9914475092167ecc5d042b238f/mouseoutgraphic/contact_us0.gif",
            "http://www.talloakscapital.com/stuff/contentmgr/files/4985c02ba05c90c9c09b09fff1594e9c/mouseoutgraphic/about_us0.gif",
            "http://www.talloakscapital.com/stuff/contentmgr/files/25ef0d08e4bd32d4b87d24d594f46673/mouseoutgraphic/our_team0.gif",
            "http://www.talloakscapital.com/stuff/contentmgr/files/866094f61d487e463336a43e49c592fe/mouseoutgraphic/portfolio0.gif",
            "http://www.talloakscapital.com/stuff/contentmgr/files/9aa40823f94bd6a46441c91ff361096c/highlightgraphic/news_and_events1.gif"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [],
        "publish_date": null,
        "summary": "",
        "meta_description": "",
        "meta_lang": "en",
        "meta_favicon": "",
        "meta_site_name": "",
        "canonical_link": null,
        "text": "News & Events\n\nCurrent NewsPortfolio News Archives\n\nCurrent News Here are some of the milestones being reached by our portfolio companies and other items of note. For links to the News & Event pages for each company, please visit our Archives page.\n\n► U.S. Postal Service Awards Contract to Persystent Technologies\n\nJune 8, 2009\n\nPersystent\n\n► Biolex Therapeutics Commences Phase 2B Trial of Locteron® in Chronic Hepatitis C\n\nApril 20, 2009\n\nBiolex\n\n► GetWellNetwork Closes $10 Million Financing\n\nMarch 3, 2009\n\nGetWellNetwork\n\n► MaxCyte Introduces the GT Flow Transfection System\n\nFebruary 17, 2009\n\nMaxCyte\n\n► GetWellNetwork Wins 2009 SmartCEO/BDO Seidman Future 50 Award\n\nJanuary 14, 2009\n\nGetWellNetwork\n\n► Aldagen announces positive results for ALD-301\n\nNovember 20, 2008\n\nAldagen\n\n► nCircle Highlighted in Deloitte's Technology Fast 50 for the Fourth Consecutive Year\n\nOctober 31, 2008\n\nnCircle\n\n► Aldagen Receives Orphan Drug Designation for ALD-101\n\nOctober 30, 2008\n\nAldagen\n\n► nCircle Partners with Microsoft to Protect Customers\n\nOctober 14, 2008\n\nnCircle\n\n► Biolex Therapeutics Completes $60 Million Series D Financing\n\nOctober 6, 2008\n\nBiolex\n\n► GetWellNetwork Signs Agreement with Adventist Health System as Exclusive Provider of IPC\n\nSeptember 15, 2008\n\nGetWellNetwork\n\n► Medinet Utilizing Maxcytes Cell Loading System in Japan\n\nAugust 20, 2008\n\nMaxCyte\n\n► Persystent Technologies Introduces New Enterprise Suite\n\nJune 17, 2008\n\nPersystent\n\n► Aldagen Files Registration Statement for Initial Public Offering\n\nMay 9, 2008\n\nAldagen\n\n► Biolex Announces Presentation of Preclinical Results for Clot Buster BLX-155\n\nMarch 18, 2008\n\nBiolex\n\n► GetWellNetwork featured in NY Times article\n\nMarch 17, 2008\n\nNew York Times\n\n► nCircle Receives Highest Customer Satisfaction Award from Info Security Product Guide\n\nFebruary 19, 2008\n\nnCircle\n\n► Biolex Therapeutics Enters into Agreement with Merck KGaA for Antibody Optimization\n\nFebruary 19, 2008\n\nBiolex\n\n► Biolex Therapeutics Commences United States Phase 2a Trial of Locteron® in Hepatitis C\n\nFebruary 7, 2008\n\nBiolex\n\n► Aldagen to Present at Leerink Swann and Wachovia Investor Conferences\n\nJanuary 23, 2008\n\nAldagen\n\n► GetWellNetwork Introduces GetConnected2008, Healthcares First Interactive Patient Care Conf\n\nDecember 17, 2008\n\nGetWellNetwork\n\n► Aldagens Adult Stem Cell Populations Shown to Regenerate Vascular Function and Repair Liver\n\nDecember 11, 2007\n\nAldagen\n\n► GetWellNetwork Named Winner of Consumer Health World Awards\n\nDecember 12, 2007\n\nGetWellNetwork\n\n► Binex and MaxCyte Collaborate on Cancer Immunotherapy Research\n\nNovember 28, 2007\n\nMaxCyte\n\n► Wipro Standardizes on Relativity Technologies\n\nOctober 30, 2007\n\nRelativity\n\n► Aldagen Announces Additional Financing\n\nRaises Additional $9 Million, Increasing Series C Financing to $23 Million\n\nSeptember 13, 2007\n\nAldagen\n\n► Medinet Licenses MaxCyte Cell Loading Technology For Cancer Immunotherapy in Japan\n\nAugust 27, 2007\n\nMaxCyte\n\n► Biolex Files for Initial Public Offering\n\nAugust 14, 2007\n\nBiolex\n\nSEC Online Filing & Forms Database (EDGAR)\n\n► Biolex Therapeutics Announces Positive Phase 2a Results for Hepatitis C Product Candidate\n\nJuly 26, 2007\n\nBiolex\n\n► GetWellNetwork, Inc. Announces the Newest Release of its Interactive Patient Care Platform\n\nJuly 17, 2007\n\nGetWellNetwork\n\n► Aldagen Announces Three New CLI Sites\n\nJuly 12, 2007\n\nAldagen\n\n► Aldagen Establishes Manufacturing Facility\n\nJuly 2, 2007\n\nAldagen\n\n► Biolex Therapeutics Completes Fundraising\n\nCompany Raises $30 Million to Advance Its Hepatitis C Drug Candidate and Other Pipeline Programs\n\nMay 24, 2007\n\nBiolex\n\n► nCircle Announces Acquisition of Cambia\n\nMay 23, 2007\n\nnCircle\n\n►GetWellNetwork, Inc. Founder Michael ONeil, Jr. Named finalist for Entrepreneur of the year.\n\nErnst & Young Entrepreneur Of The Year® 2007 Award Finalist in Greater Washington\n\nMay 15, 2007\n\nGetWellNetwork\n\n► Biolex Therapeutics Announces Strategic Collaboration with MerialCollaboration encompasses first vaccines to be produced with LEX System\n\nMay 1, 2007\n\nBiolex► nCircle Named Finalist in the 2007 SC Magazine Awards Europe\n\nApril 9, 2007\n\nnCircle\n\n► Relativity Technologies Teams with Oracle\n\nMarch 21, 2007\n\nRelativity\n\n► Biolex Therapeutics Researchers Present Preclinical Data\n\nFirst Protein Expression System to Produce Commercially Viable Levels of\n\nFull-Length Recombinant Plasmin\n\nMarch 1, 2007\n\nBiolex\n\n► GetWellNetwork Endorsed by the American Hospital Association\n\nFebruary 26, 2007\n\nGetWellNetwork\n\n► Persystent Technologies announces OEM agreement with IBM\n\nFebruary 23, 2007\n\nPersystent Technologies\n\n► Biolex Announces Initiation of Locteron Phase 2 Clinical Study in Chronic Hepatitis C\n\nJanuary 30, 2007\n\nBiolex\n\n► Record Year of Growth for Relativity Technologies\n\nJanuary 30, 2007\n\nRelativity\n\n► GWN and Inova Fair Oaks Hospital Recognized for Service Excellence by Modern Healthcare\n\nJanuary 24, 2007\n\nGetWellNetwork\n\n► MaxCyte Technology Licensed For Use In Gerons Cancer Vaccines\n\nJanuary 22, 2007\n\nMaxCyte\n\n► Biolex Announces Publication in \"Nature Biotechnology\"\n\nNovember 28, 2006\n\nBiolex\n\n► GetWellNetwork Raises $9M Series B\n\nOctober 23, 2006\n\nGetWellNetwork\n\n► SURA to Connect University Spin-offs with Investment Capital\n\nOctober 4, 2006\n\nTall Oaks Partners with the Southeastern Universities Research Association (SURA)\n\nFor SURAFund Announcement, click here. For the SURAFund Brochure, click here.\n\n► nContact Raises $7.5M Series B\n\nOctober 3, 2006\n\nDowJones VentureWire Article\n\n► Tall Oaks Portfolio Company ScholarOne Is Acquired\n\nAugust 31, 2006\n\nScholarOne\n\n► Hiram Ewald Named to CITs GAP Fund Investment Advisory Board\n\nAugust 21, 2006\n\nCenter for Innovative Technology\n\n► What Are Life Science Investors Seeking? Much More Than Just Technology\n\nJuly 6, 2006\n\nQ&A with Tall Oaks Capital Partners' Kathryne Carr\n\nWRAL LocalTechWire.Com\n\n► Relativity\n\nJune 21, 2006\n\nPartnership Announced with GT Software to Support SOA Initiatives\n\n► nCircle\n\nJune 06, 2006\n\nInfo Security Products Guide names nCircle winner of the 2006 Global Excellence in Vulnerability Assessment Award\n\n► nCircle\n\nJune 05, 2006\n\nnCircle and Cybertrust Announce Strategic Partnership\n\n► Relativity\n\nMay 31, 2006\n\nU.S. General Services Administration Modernizes with Relativity Technologies\n\n► ScholarOne\n\nMay 25, 2006\n\nSAGE Launches SAGETRACK powered by ScholarOne®\n\n► nCircle\n\nMay 12, 2006\n\nUS Patent Office Allows nCircle Vulnerability Detection Patent\n\n► Biolex\n\nApril 27, 2006\n\nBiolex Therapeutics Announces Positive Phase 1 Results For Hepatitis C Product Candidate Locteron\n\n► Biolex\n\nApril 11, 2006\n\nBiolex Therapeutics Announces Expansion Of Medarex Collaboration\n\n► Persystent\n\nMarch 29, 2006\n\nPersystent Technologies' Automated Support Prevents Desktop Disasters\n\n► Biolex\n\nMarch 23, 2006\n\nBiolex Therapeutics Receives Prestigious Award\n\n► Aldagen\n\nMarch 22, 2006\n\nAldagens Product Used to Isolate Stem Cells from Cord Blood in Human Clinical Study.\n\n► nCircle\n\nMarch 8, 2006\n\nnCircle Secures Four Places In SC Magazine European Awards Finals\n\n► MaxCyte\n\nMarch 2, 2006\n\nSangamo Biosciences Licenses MaxCyte Cell Loading Technology for ZFP Therapeutic Program for HIV/AID\n\n► ScholarOne\n\nFebruary 28, 2006\n\nScholarOne® Launches Web Services for Application Information Exchange\n\n► Aldagen\n\nFebruary 21, 2006\n\nAldagen and Texas Heart Institute to Begin Clinical Study of Stem Cell Therapy for Advanced Heart Failure Patients.\n\n► GetWellNetwork\n\nFebruary 15, 2006\n\nGetWellNetwork® Launches Focused Initiative to Transform Interactive Patient Care Solutions for Children's Hospitals\n\n► MaxCyte\n\nFebruary 15, 2006\n\nGeron Licenses MaxCyte Cell Loading Technology for Use in Closed-System Cancer Vaccine Manufacturing\n\n► nCircle\n\nFebruary 14, 2006\n\nnCircle to Unveil nCircle Focus, A Breakthrough Network Security Analysis Tool at RSA Conference\n\n► GetWellNetwork\n\nFebruary 13, 2006\n\nGetWellNetwork® Signs 12 New Agreements with U.S. Hospitals\n\n► nCircle\n\nFebruary 9, 2006\n\nnCircle Awarded Info Security Products Guide's \"Hot Companies - 2006\" Award\n\n► Persystent\n\nFebruary 9, 2006\n\nPositive Buzz for Persystent at DEMO 2006\n\n► ScholarOne\n\nFebruary 1, 2006\n\nOxford University Press Renews and Expands Its Relationship with ScholarOne®\n\n► Aldagen\n\nFebruary 1, 2006\n\nAldagen Issued Key Stem Cell Patent\n\n► Persystent\n\nFebruary 1, 2006\n\neWeek - Persystent Automates Desktop Repair\n\n► ScholarOne\n\nJanuary 26, 2006\n\nBlackwell Publishing Expands Its Relationship with ScholarOne®\n\n► Relativity\n\nJanuary 24, 2006\n\nJava Support Increases Web Services Control"
    }
}